Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hyperlipoproteinemias

  Free Subscription

Articles published in
JAMA
    July 2026
  1. RAZO C, DeCleene NK, Johnson CO, Stark BA, et al
    Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.
    JAMA. 2026 Jul 29:e268628. doi: 10.1001/jama.2026.8628.
    >> Share

  2. ANDERER S
    FDA Approves Hypertriglyceridemia Drug That May Reduce Pancreatitis Risk.
    JAMA. 2026 Jul 17. doi: 10.1001/jama.2026.9480.
    >> Share

    June 2026
  3. STEIN JH, Tattersall MC
    Familial Hypercholesterolemia.
    JAMA. 2026 Jun 29. doi: 10.1001/jama.2026.8822.
    >> Share

    March 2026
  4. BELLOWS BK, de Ferranti SD, Moran AE
    Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood-Reply.
    JAMA. 2026 Mar 25. doi: 10.1001/jama.2026.0675.
    >> Share

  5. OLSON K, Cao J, Peterson AL
    Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.
    JAMA. 2026 Mar 25. doi: 10.1001/jama.2026.0669.
    >> Share

  6. BURNS J, Daniels S, Zachariah JP
    Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.
    JAMA. 2026 Mar 25. doi: 10.1001/jama.2026.0672.
    >> Share

    November 2025
  7. BALLANTYNE CM, Gellis L, Tardif JC, Banka P, et al
    Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.
    JAMA. 2025 Nov 9:e2520620. doi: 10.1001/jama.2025.20620.
    >> Share

  8. BELLOWS BK, Zhang Y, Ruiz-Negron N, Kazi DS, et al
    Familial Hypercholesterolemia Screening in Childhood and Early Adulthood: A Cost-Effectiveness Study.
    JAMA. 2025 Nov 9:e2520648. doi: 10.1001/jama.2025.20648.
    >> Share

    January 2025
  9. NICHOLLS SJ, Ni W, Rhodes GM, Nissen SE, et al
    Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial.
    JAMA. 2025;333:222-231.
    >> Share

    July 2024
  10. KHAN SS, Lloyd-Jones DM
    Statins for Primary Prevention of Cardiovascular Disease-With PREVENT, What's a Clinician to Do?
    JAMA. 2024 Jul 29. doi: 10.1001/jama.2024.13887.
    >> Share

    May 2024
  11. HARRIS E
    Abnormal Glucose, Triglycerides Linked to Later Psychiatric Conditions.
    JAMA. 2024;331:1614-1615.
    >> Share

    December 2023
  12. HARRIS E
    High LDL Cholesterol Has Decreased Since 1999.
    JAMA. 2023;330:2044.
    >> Share

    July 2023
  13. GUIRGUIS-BLAKE JM, Evans CV, Coppola EL, Redmond N, et al
    Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;330:261-274.
    >> Share

    March 2023
  14. HONG SJ, Lee YJ, Lee SJ, Hong BK, et al
    Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
    JAMA. 2023 Mar 6:e232487. doi: 10.1001/jama.2023.2487.
    >> Share

  15. AGGARWAL R, Yeh RW, Joynt Maddox KE, Wadhera RK, et al
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020.
    JAMA. 2023 Mar 5:e232307. doi: 10.1001/jama.2023.2307.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016